CMMB

CHEMOMAB THERAPEUTICS LTD.

CMMB · CIK 1534248 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20192022
Net Income−$28M
20192022
Operating CF−$20M
20192022
Free Cash Flow−$20M
20192022

Income Statement

MetricFY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income————
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$0.12———
EPS (Diluted)$0.12———

Balance Sheet

MetricFY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.0B$0.1B$0.0B$0.0B
Current Assets$0.0B$0.1B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.1B$0.0B$0.0B

Cash Flow Statement

MetricFY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$-0.0B$0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.1B$0.0B$0.0B
← Companies